Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
European Journal of Pharmacology
|
August 14, 1991
Dopamine D1 receptor stimulation of cyclic AMP accumulation in COS-1 cells
M E Steffey, G L Snyder, R W Barrett, et al.
Neuropharmacology
|
June 16, 2000
Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia
G L Caporaso, J A Bibb, G L Snyder, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
July 25, 2022
Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D<sub>1</sub> receptor dependent mechanism
J Titulaer, O Radhe, K Danielsson, et al.
The Journal of Biological Chemistry
|
October 3, 2000
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
S Leclerc, M Garnier, R Hoessel, et al.
The Journal of Biological Chemistry
|
March 30, 2001
Phosphorylation of protein phosphatase inhibitor-1 by Cdk5
J A Bibb, A Nishi, J P O'Callaghan, et al.
Nature Neuroscience
|
June 18, 2002
DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens
R E Maldve, T A Zhang, K Ferrani-Kile, et al.
Science (New York, N.Y.)
|
February 11, 2000
Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice
S K Mani, A A Fienberg, J P O'Callaghan, et al.
Nature
|
March 27, 2001
Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5
J A Bibb, J Chen, J R Taylor, et al.
Neuroscience
|
April 8, 2006
Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity
P B Allen, V Zachariou, P Svenningsson, et al.
European Journal of Biochemistry
|
September 21, 2000
Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25
M Leost, C Schultz, A Link, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
European Journal of Pharmacology
|
August 14, 1991
Dopamine D1 receptor stimulation of cyclic AMP accumulation in COS-1 cells
M E Steffey, G L Snyder, R W Barrett, et al.
Neuropharmacology
|
June 16, 2000
Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia
G L Caporaso, J A Bibb, G L Snyder, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
July 25, 2022
Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D<sub>1</sub> receptor dependent mechanism
J Titulaer, O Radhe, K Danielsson, et al.
The Journal of Biological Chemistry
|
October 3, 2000
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
S Leclerc, M Garnier, R Hoessel, et al.
The Journal of Biological Chemistry
|
March 30, 2001
Phosphorylation of protein phosphatase inhibitor-1 by Cdk5
J A Bibb, A Nishi, J P O'Callaghan, et al.
Nature Neuroscience
|
June 18, 2002
DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens
R E Maldve, T A Zhang, K Ferrani-Kile, et al.
Science (New York, N.Y.)
|
February 11, 2000
Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice
S K Mani, A A Fienberg, J P O'Callaghan, et al.
Nature
|
March 27, 2001
Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5
J A Bibb, J Chen, J R Taylor, et al.
Neuroscience
|
April 8, 2006
Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity
P B Allen, V Zachariou, P Svenningsson, et al.
European Journal of Biochemistry
|
September 21, 2000
Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25
M Leost, C Schultz, A Link, et al.
Page
of 5